Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023GlobeNewsWire • 11/22/23
Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023GlobeNewsWire • 11/21/23
Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion DiagnosticsGlobeNewsWire • 10/30/23
Burning Rock Received Breakthrough Device Designation from China's NMPA for its Multi-Cancer Early Detection TestGlobeNewsWire • 10/15/23
Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer CellGlobeNewsWire • 09/08/23
Burning Rock Provides Second Quarter 2023 Business Updates and Schedules Earnings Release on August 31, 2023GlobeNewsWire • 08/04/23
Burning Rock's precision oncology diagnostics product supports advancement in late-stage breast cancer treatment, with results published in the New England Journal of MedicineGlobeNewsWire • 06/08/23
Is Burning Rock Biotech (BNR) Outperforming Other Business Services Stocks This Year?Zacks Investment Research • 05/30/23
Burning Rock Provides First Quarter 2023 Business Updates and Schedules Earnings Release on May 30, 2023GlobeNewsWire • 04/27/23
Burning Rock Schedules Fourth Quarter and Full Year 2022 Earnings Release on March 28, 2023GlobeNewsWire • 03/07/23
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood TestGlobeNewsWire • 01/03/23